Derma Sciences (DSCI) 8.90 $DSCI
Global Advanced Wound Care Market Outlook 2018 - Smart Dressings: Adding a New Dimension to Wound Healing
M2 - Wed Feb 11, 2:30PM CST
Research and Markets (http://www.researchandmarkets.com/research/dnlmmr/global_advanced) has announced the addition of the "Global Advanced Wound Care Market Outlook 2018" report to their offering. This new research study Global Advanced Wound Care Market Outlook 2018, reveals that the market, which was worth US$ 6.8 Billion in 2013, is expected to grow to US$ 9.1 Billion by 2018. The report has been divided into numerous sections that deal with the various aspects of the AWC market. Increased life expectancy and growing incidence of lifestyle associated disorders such as Diabetes, has resulted in increased prevalence of hard to heal wounds such as chronic foot ulcers. The inclining burden of such wounds and improved understanding of wound healing has led to the emergence of Advanced Wound Care (AWC) products and therapies. These products and therapies, though expensive initially, result in faster recoveries and hence, shorter hospital stays, resulting in overall reduced costs. This report also highlights key players and their current market share in the AWC domain. For every player, a brief business overview, geographic revenue break up and segment wise revenue break up along with key financials have been provided. A strength and weakness analysis of every player has also been presented to assist the investors in developing an understanding of the strategies of the players. At the end, a section has been dedicated to the Future Outlook, which discusses the various upcoming technologies which will further help in advancing the healing process. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the AWC. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. An Introduction 4. Drivers and Challenges 5. Market Overview 6. Market Trends and Developments 7. Competitive Landscape 8. Future Outlook Companies Mentioned - Convatec - Centaur Guernsey L.P. Inc. - Smith & Nephew - M?lnlycke Health Care - Coloplast - Hartmann Group - Derma Sciences - Integra LifeSciences For more information visit http://www.researchandmarkets.com/research/dn...l_advanced
DSCI: 8.90 (+0.02), SNN: 35.82 (-0.28)
Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement
PR Newswire - Thu Jan 22, 8:08AM CST
Derma Sciences, Inc. (Nasdaq
SCI), a tissue regeneration company focused on advanced wound care, announces that AMNIOEXCEL® and AMNIOMATRIX®, amniotic allografts derived from placental tissues, have been added to the Premier, Inc. Regenerative Skin Grafting contract portfolio. The announcement increases the opportunity for the AMNIOEXCEL® and AMNIOMATRIX® product lines, which continue to be adopted by clinicians in many health care facilities, including Veterans Administration and Military Hospitals, to be used in patient care.
DSCI: 8.90 (+0.02)
Derma Sciences Introduces 2015 Financial Guidance and Provides 2014 Preliminary Net Sales
Business Wire - Thu Jan 08, 6:30AM CST
Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, introduces financial guidance for the year ended December 31, 2015 and provides preliminary net sales for the year ended December 31, 2014.
DSCI: 8.90 (+0.02)
Insider Trading Alert - DGI, CME And DSCI Traded By Insiders
at The Street - Wed Dec 17, 10:41AM CST
Stocks with insider trader activity include DGI, CME and DSCI
DSCI: 8.90 (+0.02), CME: 93.92 (-1.39), DGI: 30.16 (+0.45)
New Consensus Guidelines and Practical Recommendations Published on the Optimal Use of Off-Loading in Diabetic Foot Ulcer Treatment
PR Newswire - Wed Dec 17, 8:03AM CST
Relieving pressure on the foot through the use of "off-loading" improves healing outcomes and reduces complications in patients with diabetic foot ulcers (DFUs), according to consensus guidelines published today in the Journal of the American Podiatric Medical Association. "The Management of Diabetic Foot Ulcers Through Optimal Off-Loading - Building Consensus Guidelines and Practical Recommendations to Improve Outcomes," was authored by a multidisciplinary panel of nine experts who were supported by Derma Sciences, Inc (Nasdaq: DSCI). The document was developed to provide evidence-based consensus on the optimal use of off-loading as treatment for DFUs, a debilitating and costly condition that can lead to amputation of the foot and other lower extremities.
DSCI: 8.90 (+0.02)
North America Traditional Wound Management Market Outlook to 2020 - Key Vendors are Medline Industries, Inc., Johnson & Johnson and Covidien plc
M2 - Mon Dec 08, 9:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/r555k6/north_america) has announced the addition of the "North America Traditional Wound Management Market Outlook to 2020" report to their offering. "North America Traditional Wound Management Market Outlook to 2020", provides key market data on the North America Traditional Wound Management market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Traditional Wound Management market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size data for Traditional Wound Management market segments - Gauzes, Sponges, Bandages, Abdominal Pads and Gauze Sponges. - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Traditional Wound Management market. - Global corporate-level profiles of key companies operating within the North America Traditional Wound Management market. - Key players covered include Medline Industries, Inc., Johnson & Johnson and Covidien plc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Traditional Wound Management Market, North America 4 Traditional Wound Management Market, Canada 5 Traditional Wound Management Market, Mexico 6 Traditional Wound Management Market, United States 7 Overview of Key Companies in North America Traditional Wound Management Market 8 Traditional Wound Management Market Pipeline Products 9 Recent Developments 10 Appendix Companies Mentioned - B. Braun Melsungen AG - BSN medical GmbH - Covidien plc - Cypress Medical Products, LLC - DUKAL Corporation - Derma Sciences, Inc. - Johnson & Johnson - Lohmann & Rauscher GmbH & Co. KG - Medline Industries, Inc. - Molnlycke Health Care AB - Paul Hartmann AG For more information visit http://www.researchandmarkets.com/research/r5...th_america
DSCI: 8.90 (+0.02), JNJ: 99.62 (+1.18)
Insider Trading Alert - FR, BHB And DSCI Traded By Insiders
at The Street - Mon Dec 08, 9:15AM CST
Stocks with insider trader activity include FR, BHB and DSCI
DSCI: 8.90 (+0.02), FR: 21.57 (-0.13), BHB: 32.38 (-0.40)
Insider Trading Alert - MNTA, DOC And DSCI Traded By Insiders
at The Street - Fri Nov 28, 9:15AM CST
Stocks with insider trader activity include MNTA, DOC and DSCI
DSCI: 8.90 (+0.02), DOC: 16.85 (+0.24), MNTA: 11.70 (-0.06)
Global Advanced Wound Care and Closure Market Report 2013-2020 - Types, Applications, End User Analysis of the $20 Billion Industry
M2 - Wed Nov 26, 6:16AM CST
Research and Markets (http://www.researchandmarkets.com/research/lrwbbc/global_advanced) has announced the addition of the "Global Advanced Wound Care and Closure Market Report 2013-2020 - Types, Applications, End User Analysis of the $20 Billion Industry" report to their offering. The global advanced wound care and closure market will reach $20.5 billion by 2020 Negative Pressure Wound Therapy (NPWT) has emerged as a highly effective therapy for advanced wound management. NPWT promotes wound healing through the application of negative pressure on the wound via foam dressings. Strong growth is anticipated in NPWT segment during the forecast period and would reach $3.7 billion by 2020. Chronic wounds are hard to heal, which take substantial time to heal and are expensive to treat. Advanced wound care and closure products are increasingly gaining popularity as standard solutions for treating chronic wounds. Traditional products are being increasingly substituted with advanced products, mainly due to their effectiveness in managing wounds by promoting faster healing. Lifestyle diseases are the cause of chronic wounds such as diabetic foot ulcer, venous leg ulcer, pressure ulcer etc. Products that treat these ulcers are gaining prominence; therefore, the major application of these products is in treating different kinds of ulcers. The advanced wound care and closure market for ulcer treatment is expected to grow over $7.8 billion by 2020 with diabetic foot ulcer management segment being prominent among all other segments. Key advanced wound care and closure manufacturers such as Smith and Nephew, Kinetic Concepts, 3M, BSN medical, Covidien, ConvaTech, Derma Sciences, Integra LifeSciences, Baxter International, Coloplast have adopted merger and acquisition and product launch as key developmental strategies in order to implement existing technologies with new products and capitalize unexplored markets. Scope of the Report MARKET BY TYPE - Advanced Wound closure - Haemostatic and sealing agents - Fibrin Sealant - Surgical Sealant - Gelatin-based Sealant - Human Fibrinogen and Thrombin Fleece - Topical Tissue Adhesive - Wound closure devices - Mechanical stapling device - Ligating clips - Wound closure strips - Others - Advanced Wound care - Moist Wound dressings - Films - Foams - Hydrocolloids - Hydrogels - Collagen - Alginates - Silver Wound Dressings - Active Wound care - Skin substitutes - Growth factors - Therapy devices - Negative Pressure Wound Therapy - Pressure relief devices MARKET BY APPLICATION - Burns - Ulcers - Pressure ulcers - Diabetic ulcers - Venous leg ulcers - Arterial ulcers - Surgical Wounds MARKET BY END-USER - Hospitals and Community Health Services - Home Healthcare Companies Mentioned - 3M - Baxter International - BSN medical - Coloplast - ConvaTech - Covidien - Derma Sciences - Integra LifeSciences - Kinetic Concepts - Smith and Nephew For more information visit http://www.researchandmarkets.com/research/lr...l_advanced
DSCI: 8.90 (+0.02), BAX: 70.39 (+0.31)
Derma Sciences To Participate in Two Upcoming Investor Conferences in December
Business Wire - Tue Nov 25, 1:05PM CST
Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, today announced that management will be participating in two upcoming investor conferences.
DSCI: 8.90 (+0.02)
North America Advanced Wound Management Market Outlook 2020: Key Vendors are 3M Health Care Ltd., Smith & Nephew Plc and ConvaTec Inc.
M2 - Tue Nov 18, 8:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/qm5kwn/north_america) has announced the addition of the "North America Advanced Wound Management Market Outlook to 2020" report to their offering. "North America Advanced Wound Management Market Outlook to 2020", provides key market data on the North America Advanced Wound Management market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Advanced Wound Management market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Scope - Market size data for Advanced Wound Management market segments - Semi-Permeable Films, Foams, Hydrofibres, Hydrocolloids, Hydrogels, Alginates, Collagens, Wound Contact Layers and Superabsorbents. - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Advanced Wound Management market. - Global corporate-level profiles of key companies operating within the North America Advanced Wound Management market. - Key players covered include 3M Health Care Ltd., Smith & Nephew Plc and ConvaTec Inc. Companies Mentioned - 3M Health Care Ltd. - BSN medical GmbH - Coloplast A/S - ConvaTec Inc. - Covidien plc - Derma Sciences, Inc. - Hollister Incorporated - Laboratoires Urgo S.A. - Medline Industries, Inc. - Molnlycke Health Care AB - Paul Hartmann AG - Smith & Nephew Plc - Systagenix Wound Management Limited For more information visit http://www.researchandmarkets.com/research/qm...th_america
DSCI: 8.90 (+0.02), SNN: 35.82 (-0.28)
Derma Sciences to Participate in Canaccord Genuity Medical Technologies and Diagnostics Forum
Business Wire - Fri Nov 14, 8:21AM CST
Derma Sciences, Inc. (Nasdaq SCI), a tissue regeneration company focused on advanced wound and burn care, today announced that Edward J. Quilty, the Company's chairman and chief executive officer will participate in a "Fireside Chat" at the Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 20th at 8:30 a.m. ET. The conference will be held at the Westin Grand Central in New York City
DSCI: 8.90 (+0.02)
Canada Compression Therapy Market Outlook to 2020: SIGVARIS, Inc., Covidien plc and BSN medical GmbH Leads the Market
M2 - Thu Nov 13, 4:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/n5g6ff/canada) has announced the addition of the "Canada Compression Therapy Market Outlook to 2020" report to their offering. "Canada Compression Therapy Market Outlook to 2020", provides key market data on the Canada Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Compression Therapy market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Compression Therapy market. - Global corporate-level profiles of key companies operating within the Canada Compression Therapy. Market Segments - Static Compression Therapy (Compression Garments (Upper and Lower Compression Garments), Compression Bandages, Anti Embolism Stockings and Diabetic Compression Socks) - Pneumatic Compression Therapy (Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps (Segmented Pneumatic Compression Pumps without Gradient and with Calibrated Gradient) and Pneumatic Compression Sleeves). Companies Mentioned - SIGVARIS, Inc. - Covidien plc - BSN medical GmbH - Smith & Nephew Plc - 3M Health Care Ltd. - Mego Afek AC LTd. - DJO Global, Inc. - Bio Compression Systems, Inc. - medi GmbH & Co. KG - ConvaTec Inc. - Lohmann & Rauscher GmbH & Co. KG - Systagenix Wound Management Limited - B. Braun Melsungen AG - Derma Sciences, Inc. - Medline Industries, Inc. - Laboratoires Urgo S.A. - Talley Group Limited - ArjoHuntleigh - Molnlycke Health Care AB - Gloria Med S.p.A. - Cardinal Health, Inc. - Juzo USA For more information visit http://www.researchandmarkets.com/research/n5g6ff/canada
DSCI: 8.90 (+0.02), SNN: 35.82 (-0.28), CAH: 86.08 (+0.04)
Brazil Compression Therapy Market Outlook to 2020 - Key Players are SIGVARIS, Inc., Covidien plc and BSN medical GmbH
M2 - Thu Nov 13, 3:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/4n655s/brazil) has announced the addition of the "Brazil Compression Therapy Market Outlook to 2020" report to their offering. "Brazil Compression Therapy Market Outlook to 2020", provides key market data on the Brazil Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Compression Therapy market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Compression Therapy market. - Global corporate-level profiles of key companies operating within the Brazil Compression Therapy. Market Segments - Static Compression Therapy (Compression Garments (Upper and Lower Compression Garments), Compression Bandages and Anti Embolism Stockings) - Pneumatic Compression Therapy (Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps (Segmented Pneumatic Compression Pumps without Gradient and with Calibrated Gradient) and Pneumatic Compression Sleeves). Companies Mentioned - SIGVARIS, Inc. - Covidien plc - BSN medical GmbH - 3M Health Care Ltd. - Daesung Maref Co., Ltd - Lohmann & Rauscher GmbH & Co. KG - medi GmbH & Co. KG - Salzmann AG - Medline Industries, Inc. - Paul Hartmann AG - Laboratoires Innothera - Smith & Nephew Plc - Derma Sciences, Inc. - Mego Afek AC LTd. - ArjoHuntleigh - B. Braun Melsungen AG For more information visit http://www.researchandmarkets.com/research/4n655s/brazil
DSCI: 8.90 (+0.02), SNN: 35.82 (-0.28)
North America Compression Therapy Market Outlook to 2020: Key Players are Covidien plc, BSN medical GmbH and SIGVARIS, Inc.
M2 - Wed Nov 12, 5:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/z9bhqr/north_america) has announced the addition of the "North America Compression Therapy Market Outlook to 2020" report to their offering. "North America Compression Therapy Market Outlook to 2020", provides key market data on the North America Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Compression Therapy market. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Market Segments - Static Compression Therapy (Compression Garments (Upper and Lower Compression Garments), Compression Bandages, Anti Embolism Stockings and Diabetic Compression Socks) - Pneumatic Compression Therapy (Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps (Segmented Pneumatic Compression Pumps without Gradient and with Calibrated Gradient) and Pneumatic Compression Sleeves). Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Compression Therapy Market, North America 4 Compression Therapy Market, Canada 5 Compression Therapy Market, Mexico 6 Compression Therapy Market, United States 7 Overview of Key Companies in North America Compression Therapy Market 8 Recent Developments 9 Appendix Companies Mentioned - SIGVARIS, Inc. - Covidien plc - BSN medical GmbH - Medline Industries, Inc. - THUASNE SA - 3M Health Care Ltd. - Juzo USA - DJO Global, Inc. - Bio Compression Systems, Inc. - Mego Afek AC LTd. - medi GmbH & Co. KG - ArjoHuntleigh - Salzmann AG - Derma Sciences, Inc. - B. Braun Melsungen AG - Lohmann & Rauscher GmbH & Co. KG - Paul Hartmann AG - Laboratoires Innothera For more information visit http://www.researchandmarkets.com/research/z9...th_america
DSCI: 8.90 (+0.02)
Nasdaq stocks posting largest percentage decreases
AP - Tue Nov 11, 12:52PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
CLUB: 6.94 (+0.10), CBPO: 69.12 (+0.42), DSCI: 8.90 (+0.02), HYGS: 14.25 (-0.28), MYGN: 34.03 (+0.40), MCEP: 6.29 (+0.12), HIIQ: 8.03 (+0.16), HYG.TO: 17.60 (-0.51), SLTC: 4.84 (+0.02), ASEI: 56.82 (+0.30), MTEX: 23.89 (+0.69), PLNR: 6.63 (-0.07)
Derma Sciences' (DSCI) CEO Ed Quilty on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 5:37PM CST
DSCI: 8.90 (+0.02)
Derma Sciences lowers sales guidance after Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 12:28PM CST
DSCI: 8.90 (+0.02)
Diabetic Foot Ulcers Therapeutics Pipeline Report H2 2014 - Analysis of 26 Companies & 37 Drug Profiles
M2 - Mon Nov 10, 10:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/b997sg/diabetic_foot) has announced the addition of the "Diabetic Foot Ulcers - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Diabetic Foot Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diabetic Foot Ulcers and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Derma Sciences, Inc. - GlaxoSmithKline plc - CardioVascular BioTherapeutics, Inc. - Stratatech Corporation - Tissue Med Biosciences - Reliance Life Sciences Pvt. Ltd. - Celgene Corporation - Kaken Pharmaceutical Co., Ltd. - CytoTools AG - NovaLead Pharma Pvt. Ltd. - FirstString Research, Inc. - Lumosa Therapeutics Co., Ltd. - CoDa Therapeutics, Inc. - Adocia - Plurogen Therapeutics, Inc. - EyeGene, Inc. - Izun Pharmaceuticals Corporation - MacroCure - Royer Biomedical, Inc. - Oneness Biotech Co., Ltd. - Aprogen, Inc. - Pergamum AB - Dipexium Pharmaceuticals LLC - Kasiak Research Pvt. Ltd. - Innovaxis - Grupo Praxis Pharmaceutical SA Drug Profiles - pexiganan acetate - DermaPro - trafermin - Recombinant Protein to Agonize Platelet Derived Growth Factor Receptor for Metabolic and Dermatology Diseases - ON-101 - DSC-127 - CureXcell - Granexin - Vivefoot - ReliDerm-DT - CVBT-141B - CODA-001 - PX-070101 - IZN-6D4 - CSTC-1 - PluroGel N - esmolol hydrochloride - gentamicin sulfate - GSK-1278863 - PDA-002 - TMBP-3 - coagulation factor XIVa (human) - AP-102 - Cyndacel-M - EG-Decorin - STD-06 - Nu-2 - Nu-3 - MT-003 - Cell Therapy to Activate VEGF for Venous Leg Ulcers and Diabetic Foot Ulcers For more information visit http://www.researchandmarkets.com/research/b9...betic_foot
DSCI: 8.90 (+0.02), DPRX: 12.76 (+0.26), GSK: 47.94 (+1.99), CELGZ: 3.17 (-0.04)
Derma Sciences posts 3Q loss
Automated Insights - Mon Nov 10, 6:39AM CST
PRINCETON, N.J. (AP) _ Derma Sciences Inc. (DSCI) on Monday reported a loss of $11.2 million, or 45 cents per share, in its third quarter.
DSCI: 8.90 (+0.02)
Global Advanced Wound Care Market Outlook 2018 - Smart Dressings: Adding a New Dimension to Wound Healing
M2 - Wed Feb 11, 2:30PM CST
Research and Markets (http://www.researchandmarkets.com/research/dnlmmr/global_advanced) has announced the addition of the "Global Advanced Wound Care Market Outlook 2018" report to their offering. This new research study Global Advanced Wound Care Market Outlook 2018, reveals that the market, which was worth US$ 6.8 Billion in 2013, is expected to grow to US$ 9.1 Billion by 2018. The report has been divided into numerous sections that deal with the various aspects of the AWC market. Increased life expectancy and growing incidence of lifestyle associated disorders such as Diabetes, has resulted in increased prevalence of hard to heal wounds such as chronic foot ulcers. The inclining burden of such wounds and improved understanding of wound healing has led to the emergence of Advanced Wound Care (AWC) products and therapies. These products and therapies, though expensive initially, result in faster recoveries and hence, shorter hospital stays, resulting in overall reduced costs. This report also highlights key players and their current market share in the AWC domain. For every player, a brief business overview, geographic revenue break up and segment wise revenue break up along with key financials have been provided. A strength and weakness analysis of every player has also been presented to assist the investors in developing an understanding of the strategies of the players. At the end, a section has been dedicated to the Future Outlook, which discusses the various upcoming technologies which will further help in advancing the healing process. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the AWC. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. An Introduction 4. Drivers and Challenges 5. Market Overview 6. Market Trends and Developments 7. Competitive Landscape 8. Future Outlook Companies Mentioned - Convatec - Centaur Guernsey L.P. Inc. - Smith & Nephew - M?lnlycke Health Care - Coloplast - Hartmann Group - Derma Sciences - Integra LifeSciences For more information visit http://www.researchandmarkets.com/research/dn...l_advanced
DSCI: 8.90 (+0.02), SNN: 35.82 (-0.28)
Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement
PR Newswire - Thu Jan 22, 8:08AM CST
Derma Sciences, Inc. (Nasdaq
SCI), a tissue regeneration company focused on advanced wound care, announces that AMNIOEXCEL® and AMNIOMATRIX®, amniotic allografts derived from placental tissues, have been added to the Premier, Inc. Regenerative Skin Grafting contract portfolio. The announcement increases the opportunity for the AMNIOEXCEL® and AMNIOMATRIX® product lines, which continue to be adopted by clinicians in many health care facilities, including Veterans Administration and Military Hospitals, to be used in patient care. DSCI: 8.90 (+0.02)
Derma Sciences Introduces 2015 Financial Guidance and Provides 2014 Preliminary Net Sales
Business Wire - Thu Jan 08, 6:30AM CST
Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, introduces financial guidance for the year ended December 31, 2015 and provides preliminary net sales for the year ended December 31, 2014.
DSCI: 8.90 (+0.02)
Insider Trading Alert - DGI, CME And DSCI Traded By Insiders
at The Street - Wed Dec 17, 10:41AM CST
Stocks with insider trader activity include DGI, CME and DSCI
DSCI: 8.90 (+0.02), CME: 93.92 (-1.39), DGI: 30.16 (+0.45)
New Consensus Guidelines and Practical Recommendations Published on the Optimal Use of Off-Loading in Diabetic Foot Ulcer Treatment
PR Newswire - Wed Dec 17, 8:03AM CST
Relieving pressure on the foot through the use of "off-loading" improves healing outcomes and reduces complications in patients with diabetic foot ulcers (DFUs), according to consensus guidelines published today in the Journal of the American Podiatric Medical Association. "The Management of Diabetic Foot Ulcers Through Optimal Off-Loading - Building Consensus Guidelines and Practical Recommendations to Improve Outcomes," was authored by a multidisciplinary panel of nine experts who were supported by Derma Sciences, Inc (Nasdaq: DSCI). The document was developed to provide evidence-based consensus on the optimal use of off-loading as treatment for DFUs, a debilitating and costly condition that can lead to amputation of the foot and other lower extremities.
DSCI: 8.90 (+0.02)
North America Traditional Wound Management Market Outlook to 2020 - Key Vendors are Medline Industries, Inc., Johnson & Johnson and Covidien plc
M2 - Mon Dec 08, 9:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/r555k6/north_america) has announced the addition of the "North America Traditional Wound Management Market Outlook to 2020" report to their offering. "North America Traditional Wound Management Market Outlook to 2020", provides key market data on the North America Traditional Wound Management market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Traditional Wound Management market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size data for Traditional Wound Management market segments - Gauzes, Sponges, Bandages, Abdominal Pads and Gauze Sponges. - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Traditional Wound Management market. - Global corporate-level profiles of key companies operating within the North America Traditional Wound Management market. - Key players covered include Medline Industries, Inc., Johnson & Johnson and Covidien plc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Traditional Wound Management Market, North America 4 Traditional Wound Management Market, Canada 5 Traditional Wound Management Market, Mexico 6 Traditional Wound Management Market, United States 7 Overview of Key Companies in North America Traditional Wound Management Market 8 Traditional Wound Management Market Pipeline Products 9 Recent Developments 10 Appendix Companies Mentioned - B. Braun Melsungen AG - BSN medical GmbH - Covidien plc - Cypress Medical Products, LLC - DUKAL Corporation - Derma Sciences, Inc. - Johnson & Johnson - Lohmann & Rauscher GmbH & Co. KG - Medline Industries, Inc. - Molnlycke Health Care AB - Paul Hartmann AG For more information visit http://www.researchandmarkets.com/research/r5...th_america
DSCI: 8.90 (+0.02), JNJ: 99.62 (+1.18)
Insider Trading Alert - FR, BHB And DSCI Traded By Insiders
at The Street - Mon Dec 08, 9:15AM CST
Stocks with insider trader activity include FR, BHB and DSCI
DSCI: 8.90 (+0.02), FR: 21.57 (-0.13), BHB: 32.38 (-0.40)
Insider Trading Alert - MNTA, DOC And DSCI Traded By Insiders
at The Street - Fri Nov 28, 9:15AM CST
Stocks with insider trader activity include MNTA, DOC and DSCI
DSCI: 8.90 (+0.02), DOC: 16.85 (+0.24), MNTA: 11.70 (-0.06)
Global Advanced Wound Care and Closure Market Report 2013-2020 - Types, Applications, End User Analysis of the $20 Billion Industry
M2 - Wed Nov 26, 6:16AM CST
Research and Markets (http://www.researchandmarkets.com/research/lrwbbc/global_advanced) has announced the addition of the "Global Advanced Wound Care and Closure Market Report 2013-2020 - Types, Applications, End User Analysis of the $20 Billion Industry" report to their offering. The global advanced wound care and closure market will reach $20.5 billion by 2020 Negative Pressure Wound Therapy (NPWT) has emerged as a highly effective therapy for advanced wound management. NPWT promotes wound healing through the application of negative pressure on the wound via foam dressings. Strong growth is anticipated in NPWT segment during the forecast period and would reach $3.7 billion by 2020. Chronic wounds are hard to heal, which take substantial time to heal and are expensive to treat. Advanced wound care and closure products are increasingly gaining popularity as standard solutions for treating chronic wounds. Traditional products are being increasingly substituted with advanced products, mainly due to their effectiveness in managing wounds by promoting faster healing. Lifestyle diseases are the cause of chronic wounds such as diabetic foot ulcer, venous leg ulcer, pressure ulcer etc. Products that treat these ulcers are gaining prominence; therefore, the major application of these products is in treating different kinds of ulcers. The advanced wound care and closure market for ulcer treatment is expected to grow over $7.8 billion by 2020 with diabetic foot ulcer management segment being prominent among all other segments. Key advanced wound care and closure manufacturers such as Smith and Nephew, Kinetic Concepts, 3M, BSN medical, Covidien, ConvaTech, Derma Sciences, Integra LifeSciences, Baxter International, Coloplast have adopted merger and acquisition and product launch as key developmental strategies in order to implement existing technologies with new products and capitalize unexplored markets. Scope of the Report MARKET BY TYPE - Advanced Wound closure - Haemostatic and sealing agents - Fibrin Sealant - Surgical Sealant - Gelatin-based Sealant - Human Fibrinogen and Thrombin Fleece - Topical Tissue Adhesive - Wound closure devices - Mechanical stapling device - Ligating clips - Wound closure strips - Others - Advanced Wound care - Moist Wound dressings - Films - Foams - Hydrocolloids - Hydrogels - Collagen - Alginates - Silver Wound Dressings - Active Wound care - Skin substitutes - Growth factors - Therapy devices - Negative Pressure Wound Therapy - Pressure relief devices MARKET BY APPLICATION - Burns - Ulcers - Pressure ulcers - Diabetic ulcers - Venous leg ulcers - Arterial ulcers - Surgical Wounds MARKET BY END-USER - Hospitals and Community Health Services - Home Healthcare Companies Mentioned - 3M - Baxter International - BSN medical - Coloplast - ConvaTech - Covidien - Derma Sciences - Integra LifeSciences - Kinetic Concepts - Smith and Nephew For more information visit http://www.researchandmarkets.com/research/lr...l_advanced
DSCI: 8.90 (+0.02), BAX: 70.39 (+0.31)
Derma Sciences To Participate in Two Upcoming Investor Conferences in December
Business Wire - Tue Nov 25, 1:05PM CST
Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, today announced that management will be participating in two upcoming investor conferences.
DSCI: 8.90 (+0.02)
North America Advanced Wound Management Market Outlook 2020: Key Vendors are 3M Health Care Ltd., Smith & Nephew Plc and ConvaTec Inc.
M2 - Tue Nov 18, 8:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/qm5kwn/north_america) has announced the addition of the "North America Advanced Wound Management Market Outlook to 2020" report to their offering. "North America Advanced Wound Management Market Outlook to 2020", provides key market data on the North America Advanced Wound Management market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Advanced Wound Management market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Scope - Market size data for Advanced Wound Management market segments - Semi-Permeable Films, Foams, Hydrofibres, Hydrocolloids, Hydrogels, Alginates, Collagens, Wound Contact Layers and Superabsorbents. - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Advanced Wound Management market. - Global corporate-level profiles of key companies operating within the North America Advanced Wound Management market. - Key players covered include 3M Health Care Ltd., Smith & Nephew Plc and ConvaTec Inc. Companies Mentioned - 3M Health Care Ltd. - BSN medical GmbH - Coloplast A/S - ConvaTec Inc. - Covidien plc - Derma Sciences, Inc. - Hollister Incorporated - Laboratoires Urgo S.A. - Medline Industries, Inc. - Molnlycke Health Care AB - Paul Hartmann AG - Smith & Nephew Plc - Systagenix Wound Management Limited For more information visit http://www.researchandmarkets.com/research/qm...th_america
DSCI: 8.90 (+0.02), SNN: 35.82 (-0.28)
Derma Sciences to Participate in Canaccord Genuity Medical Technologies and Diagnostics Forum
Business Wire - Fri Nov 14, 8:21AM CST
Derma Sciences, Inc. (Nasdaq
SCI), a tissue regeneration company focused on advanced wound and burn care, today announced that Edward J. Quilty, the Company's chairman and chief executive officer will participate in a "Fireside Chat" at the Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 20th at 8:30 a.m. ET. The conference will be held at the Westin Grand Central in New York City DSCI: 8.90 (+0.02)
Canada Compression Therapy Market Outlook to 2020: SIGVARIS, Inc., Covidien plc and BSN medical GmbH Leads the Market
M2 - Thu Nov 13, 4:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/n5g6ff/canada) has announced the addition of the "Canada Compression Therapy Market Outlook to 2020" report to their offering. "Canada Compression Therapy Market Outlook to 2020", provides key market data on the Canada Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Compression Therapy market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Compression Therapy market. - Global corporate-level profiles of key companies operating within the Canada Compression Therapy. Market Segments - Static Compression Therapy (Compression Garments (Upper and Lower Compression Garments), Compression Bandages, Anti Embolism Stockings and Diabetic Compression Socks) - Pneumatic Compression Therapy (Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps (Segmented Pneumatic Compression Pumps without Gradient and with Calibrated Gradient) and Pneumatic Compression Sleeves). Companies Mentioned - SIGVARIS, Inc. - Covidien plc - BSN medical GmbH - Smith & Nephew Plc - 3M Health Care Ltd. - Mego Afek AC LTd. - DJO Global, Inc. - Bio Compression Systems, Inc. - medi GmbH & Co. KG - ConvaTec Inc. - Lohmann & Rauscher GmbH & Co. KG - Systagenix Wound Management Limited - B. Braun Melsungen AG - Derma Sciences, Inc. - Medline Industries, Inc. - Laboratoires Urgo S.A. - Talley Group Limited - ArjoHuntleigh - Molnlycke Health Care AB - Gloria Med S.p.A. - Cardinal Health, Inc. - Juzo USA For more information visit http://www.researchandmarkets.com/research/n5g6ff/canada
DSCI: 8.90 (+0.02), SNN: 35.82 (-0.28), CAH: 86.08 (+0.04)
Brazil Compression Therapy Market Outlook to 2020 - Key Players are SIGVARIS, Inc., Covidien plc and BSN medical GmbH
M2 - Thu Nov 13, 3:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/4n655s/brazil) has announced the addition of the "Brazil Compression Therapy Market Outlook to 2020" report to their offering. "Brazil Compression Therapy Market Outlook to 2020", provides key market data on the Brazil Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Compression Therapy market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Compression Therapy market. - Global corporate-level profiles of key companies operating within the Brazil Compression Therapy. Market Segments - Static Compression Therapy (Compression Garments (Upper and Lower Compression Garments), Compression Bandages and Anti Embolism Stockings) - Pneumatic Compression Therapy (Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps (Segmented Pneumatic Compression Pumps without Gradient and with Calibrated Gradient) and Pneumatic Compression Sleeves). Companies Mentioned - SIGVARIS, Inc. - Covidien plc - BSN medical GmbH - 3M Health Care Ltd. - Daesung Maref Co., Ltd - Lohmann & Rauscher GmbH & Co. KG - medi GmbH & Co. KG - Salzmann AG - Medline Industries, Inc. - Paul Hartmann AG - Laboratoires Innothera - Smith & Nephew Plc - Derma Sciences, Inc. - Mego Afek AC LTd. - ArjoHuntleigh - B. Braun Melsungen AG For more information visit http://www.researchandmarkets.com/research/4n655s/brazil
DSCI: 8.90 (+0.02), SNN: 35.82 (-0.28)
North America Compression Therapy Market Outlook to 2020: Key Players are Covidien plc, BSN medical GmbH and SIGVARIS, Inc.
M2 - Wed Nov 12, 5:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/z9bhqr/north_america) has announced the addition of the "North America Compression Therapy Market Outlook to 2020" report to their offering. "North America Compression Therapy Market Outlook to 2020", provides key market data on the North America Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Compression Therapy market. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Market Segments - Static Compression Therapy (Compression Garments (Upper and Lower Compression Garments), Compression Bandages, Anti Embolism Stockings and Diabetic Compression Socks) - Pneumatic Compression Therapy (Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps (Segmented Pneumatic Compression Pumps without Gradient and with Calibrated Gradient) and Pneumatic Compression Sleeves). Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Compression Therapy Market, North America 4 Compression Therapy Market, Canada 5 Compression Therapy Market, Mexico 6 Compression Therapy Market, United States 7 Overview of Key Companies in North America Compression Therapy Market 8 Recent Developments 9 Appendix Companies Mentioned - SIGVARIS, Inc. - Covidien plc - BSN medical GmbH - Medline Industries, Inc. - THUASNE SA - 3M Health Care Ltd. - Juzo USA - DJO Global, Inc. - Bio Compression Systems, Inc. - Mego Afek AC LTd. - medi GmbH & Co. KG - ArjoHuntleigh - Salzmann AG - Derma Sciences, Inc. - B. Braun Melsungen AG - Lohmann & Rauscher GmbH & Co. KG - Paul Hartmann AG - Laboratoires Innothera For more information visit http://www.researchandmarkets.com/research/z9...th_america
DSCI: 8.90 (+0.02)
Nasdaq stocks posting largest percentage decreases
AP - Tue Nov 11, 12:52PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
CLUB: 6.94 (+0.10), CBPO: 69.12 (+0.42), DSCI: 8.90 (+0.02), HYGS: 14.25 (-0.28), MYGN: 34.03 (+0.40), MCEP: 6.29 (+0.12), HIIQ: 8.03 (+0.16), HYG.TO: 17.60 (-0.51), SLTC: 4.84 (+0.02), ASEI: 56.82 (+0.30), MTEX: 23.89 (+0.69), PLNR: 6.63 (-0.07)
Derma Sciences' (DSCI) CEO Ed Quilty on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 5:37PM CST
DSCI: 8.90 (+0.02)
Derma Sciences lowers sales guidance after Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 12:28PM CST
DSCI: 8.90 (+0.02)
Diabetic Foot Ulcers Therapeutics Pipeline Report H2 2014 - Analysis of 26 Companies & 37 Drug Profiles
M2 - Mon Nov 10, 10:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/b997sg/diabetic_foot) has announced the addition of the "Diabetic Foot Ulcers - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Diabetic Foot Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diabetic Foot Ulcers and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Derma Sciences, Inc. - GlaxoSmithKline plc - CardioVascular BioTherapeutics, Inc. - Stratatech Corporation - Tissue Med Biosciences - Reliance Life Sciences Pvt. Ltd. - Celgene Corporation - Kaken Pharmaceutical Co., Ltd. - CytoTools AG - NovaLead Pharma Pvt. Ltd. - FirstString Research, Inc. - Lumosa Therapeutics Co., Ltd. - CoDa Therapeutics, Inc. - Adocia - Plurogen Therapeutics, Inc. - EyeGene, Inc. - Izun Pharmaceuticals Corporation - MacroCure - Royer Biomedical, Inc. - Oneness Biotech Co., Ltd. - Aprogen, Inc. - Pergamum AB - Dipexium Pharmaceuticals LLC - Kasiak Research Pvt. Ltd. - Innovaxis - Grupo Praxis Pharmaceutical SA Drug Profiles - pexiganan acetate - DermaPro - trafermin - Recombinant Protein to Agonize Platelet Derived Growth Factor Receptor for Metabolic and Dermatology Diseases - ON-101 - DSC-127 - CureXcell - Granexin - Vivefoot - ReliDerm-DT - CVBT-141B - CODA-001 - PX-070101 - IZN-6D4 - CSTC-1 - PluroGel N - esmolol hydrochloride - gentamicin sulfate - GSK-1278863 - PDA-002 - TMBP-3 - coagulation factor XIVa (human) - AP-102 - Cyndacel-M - EG-Decorin - STD-06 - Nu-2 - Nu-3 - MT-003 - Cell Therapy to Activate VEGF for Venous Leg Ulcers and Diabetic Foot Ulcers For more information visit http://www.researchandmarkets.com/research/b9...betic_foot
DSCI: 8.90 (+0.02), DPRX: 12.76 (+0.26), GSK: 47.94 (+1.99), CELGZ: 3.17 (-0.04)
Derma Sciences posts 3Q loss
Automated Insights - Mon Nov 10, 6:39AM CST
PRINCETON, N.J. (AP) _ Derma Sciences Inc. (DSCI) on Monday reported a loss of $11.2 million, or 45 cents per share, in its third quarter.
DSCI: 8.90 (+0.02)
